Comparison of Somatostatin Analogue (SA) and Chemotherapy (CT) in Neuroendocrine Tumors (NET) Patients with Ki-67 <= 20%

Date

2016

Author

Özaslan, E.
Koca, S.
Sevinç, A.
Hacıoğlu, B.
Özçelik, M.
Duran, A. O.
Çiltaş, A.
Özgür, Tanrıverdi

Metadata

Show full item record

Abstract

[No abstract available]

Source

Neuroendocrinology

Volume

103

URI

https://hdl.handle.net/20.500.12809/2682

Collections